天津天士力集团复方丹参滴丸成功通过俄罗斯卫生部处方药注册 ,获准在俄罗斯上市。申报过程 :复方丹参滴丸通过了俄罗斯药典委员会、管理委员会的审查 ,并在俄罗斯科学院、心脏病权威专家指导下 ,在几家俄罗斯国家临床医院进行严格的临床试验。临床结果表明 ,复方丹参滴丸对心 The Tianjin Tasly Group Compound Danshen Dripping Pill has successfully registered through the Russian Ministry of Health Prescription Drugs and is approved to be listed in Russia. Declaration process: Compound Danshen Dripping Pills passed the review of the Russian Pharmacopoeia Commission and the Management Committee, and under the guidance of Russian Academy of Sciences and authoritative experts on heart disease, strict clinical trials were conducted at several Russian national clinical hospitals. Clinical results show that Compound Danshen Dripping Pills